Kliniczne aspekty chorób serca: część 1 i 2 | Clinical Aspects of Heart Diseases: part 1 and 2

.tooltip { position: relative; cursor: pointer; text-decoration: none; border-bottom: 1px dashed rgba(0, 0, 0, 0.6); } .tooltip::before { content: attr(data-tooltip); position: absolute; top: -40px; /* Trochę niżej nad słowem */ left: 50%; /* Wyśrodkowanie */ transform: translateX(-50%); background-color: rgba(255, 255, 255, 0.9); color: #333; padding: 6px 12px; border-radius: 8px; white-space: nowrap; opacity: 0; visibility: hidden; transition: opacity 0.3s ease, visibility 0.3s ease; font-family: ‘Arial’, sans-serif; font-size: 14px; box-shadow: 0px 4px 8px rgba(0, 0, 0, 0.1); z-index: 10; } .tooltip:hover::before { opacity: 1; visibility: visible; } document.addEventListener(‘DOMContentLoaded’, function () { const wordsToTooltip = { “Valvular Heart Disease”: “Choroba zastawek serca”, “heart valves”: “Zastawki serca”, “valvular disease”: “Choroba zastawek”, “stenosis”: “Zwężenie”, “regurgitation”: “Niedomykalność”, “backward flow”: “Przepływ wsteczny”, “aortic valve”: “Zastawka aortalna”, “mitral valve”: “Zastawka mitralna”, “tricuspid valve”: “Zastawka trójdzielna”, “pulmonary valve”: “Zastawka płucna”, “aortic stenosis”: “Zwężenie zastawki aortalnej”, “aortic valve narrowing”: “Zwężenie zastawki aortalnej”, “restricted blood flow”: “Ograniczony przepływ krwi”, “chest pain”: “Ból w klatce piersiowej”, “shortness of breath”: “Duszność”, “syncope”: “Omdlenie”, “mitral regurgitation”: “Niedomykalność zastawki mitralnej”, “backflow into left atrium”: “Przepływ wsteczny do lewego przedsionka”, “dyspnea on exertion”: “Duszność przy wysiłku”, “palpitations”: “Kołatanie serca”, “mitral stenosis”: “Zwężenie zastawki mitralnej”, “blood flow impediment”: “Utrudniony przepływ krwi”, “hemoptysis”: “Krwioplucie”, “aortic regurgitation”: “Niedomykalność zastawki aortalnej”, “blood leak”: “Przeciek krwi”, “rheumatic fever”: “Gorączka reumatyczna”, “streptococcal infections”: “Zakażenia paciorkowcowe”, “congenital heart defects”: “Wrodzone wady serca”, “bicuspid aortic valve”: “Dwupłatkowa zastawka aortalna”, “age-related degeneration”: “Degeneracja związana z wiekiem”, “calcification”: “Zwapnienie”, “fibrosis”: “Zwłóknienie”, “infective endocarditis”: “Infekcyjne zapalenie wsierdzia”, “connective tissue disorders”: “Choroby tkanki łącznej”, “Marfan syndrome”: “Zespół Marfana”, “previous myocardial infarction”: “Przebyty zawał mięśnia sercowego”, “autoimmune diseases”: “Choroby autoimmunologiczne”, “obstruction of blood flow”: “Zablokowanie przepływu krwi”, “ventricular hypertrophy”: “Przerost komory serca”, “atrial dilation”: “Poszerzenie przedsionka”, “congestive heart failure”: “Zastoinowa niewydolność serca”, “angina”: “Dławica piersiowa”, “pulmonary congestion”: “Obrzęk płuc”, “fatigue”: “Zmęczenie”, “heart murmur”: “Szmer serca”, “atrial fibrillation”: “Migotanie przedsionków”, “peripheral edema”: “Obrzęki obwodowe”, “echocardiogram”: “Echokardiogram”, “valve function”: “Funkcja zastawek”, “chest X-ray”: “RTG klatki piersiowej”, “heart size”: “Wielkość serca”, “pulmonary congestion”: “Przekrwienie płucne”, “electrocardiogram (ECG)”: “Elektrokardiogram”, “atrial enlargement”: “Powiększenie przedsionka”, “ventricular hypertrophy”: “Przerost komory serca”, “cardiac catheterization”: “Cewnikowanie serca”, “MRI”: “Rezonans magnetyczny”, “CT scan”: “Tomografia komputerowa”, “diuretics”: “Diuretyki”, “fluid overload relief”: “Łagodzenie przeciążenia płynami”, “beta-blockers”: “Beta-blokery”, “calcium channel blockers”: “Blokery kanału wapniowego”, “heart rate management”: “Kontrola rytmu serca”, “anticoagulants”: “Antykoagulanty”, “stroke prevention”: “Zapobieganie udarom”, “valve repair”: “Naprawa zastawek”, “valve replacement”: “Wymiana zastawek”, “mechanical valves”: “Zastawki mechaniczne”, “bioprosthetic valves”: “Zastawki bioprotezowe”, “transcatheter aortic valve replacement (TAVR)”: “Przezcewnikowa wymiana zastawki aortalnej”, “balloon valvuloplasty”: “Walwuloplastyka balonowa”, “lifestyle modifications”: “Modyfikacje stylu życia”, “sodium intake reduction”: “Ograniczenie spożycia sodu”, “exercise plan”: “Plan ćwiczeń”, “heart failure”: “Niewydolność serca”, “arrhythmias”: “Arytmie”, “atrial fibrillation”: “Migotanie przedsionków”, “pulmonary hypertension”: “Nadciśnienie płucne”, “thromboembolism”: “Zatorowość”, “infective endocarditis”: “Infekcyjne zapalenie wsierdzia”, “blood clots”: “Zakrzepy”, “aortic stenosis (AS)”: “Zwężenie zastawki aortalnej”, “mitral regurgitation (MR)”: “Niedomykalność zastawki mitralnej”, “mitral stenosis (MS)”: “Zwężenie zastawki mitralnej”, “aortic regurgitation (AR)”: “Niedomykalność zastawki aortalnej”, “congestive heart failure (CHF)”: “Zastoinowa niewydolność serca”, “impeding”: “Utrudnianie”, “dyspnea”: “Duszność”, “water hammer pulse”: “Tętno “młota pneumatycznego””, “hypertrophy”: “Przerost”, “ventricles”: “Komory serca”, “dilation”: “Rozstrzeń”, “atria”: “Przedsionki”, “cardiac output”: “Rzut serca”, “auscultation”: “Osłuchiwanie”, “coronary artery disease”: “Choroba wieńcowa”, “stroke”: “Udar mózgu”, “mitral valve disease”: “Choroba zastawki mitralnej”, “prosthetic valves”: “Protezy zastawek”, “asymptomatic”: “Bezobjawowy”, “life expectancy”: “Oczekiwana długość życia”, “close follow-up”: “Ścisła obserwacja”, “untreated”: “Nieleczony”, “left ventricular dysfunction”: “Dysfunkcja lewej komory serca”, “survival rate”: “Wskaźnik przeżycia”, “percutaneous balloon valvuloplasty”: “Przezskórna balonowa walwuloplastyka”, “alleviate symptoms”: “Łagodzić objawy”, “Early Stages”: “Wczesne etapy”, “Severe MR”: “Ciężka niedomykalność zastawki mitralnej”, “Mild Cases”: “Łagodne przypadki”, “Severe MS”: “Ciężkie zwężenie zastawki mitralnej”, “Chronic Asymptomatic AR”: “Przewlekła bezobjawowa niedomykalność zastawki aortalnej”, “Symptomatic AR”: “Objawowa niedomykalność zastawki aortalnej”, “comorbidities”: “Choroby współistniejące”, “chronic condition”: “Przewlekła choroba”, “ventricle”: “Komora serca”, “fluid buildup”: “Nagromadzenie płynu”, “orthopnea”: “Dusznica ortopnoiczna”, “paroxysmal nocturnal dyspnea”: “Napadowa duszność nocna”, “swelling”: “Obrzęk”, “jugular venous distension”: “Poszerzenie żył szyjnych”, “Coronary Artery Disease”: “Choroba wieńcowa”, “ischemic damage”: “Uszkodzenie niedokrwienne”, “Hypertension”: “Nadciśnienie”, “Cardiomyopathy”: “Kardiomiopatia”, “Diabetes”: “Cukrzyca”, “sedentary lifestyle”: “Siedzący tryb życia”, “sympathetic nervous system”: “Układ współczulny”, “strain”: “Obciążenie”, “exertion”: “Wysiłek”, “central venous pressure”: “Centralne ciśnienie żylne”, “frothy sputum”: “Pienista plwocina”, “crackles”: “Trzeszczenia”, “ejection fraction”: “Frakcja wyrzutowa”, “B-type Natriuretic Peptide”: “Peptyd natriuretyczny typu B”, “thyroid function”: “Funkcja tarczycy”, “markers of heart damage”: “Markery uszkodzenia serca”, “kidney function”: “Funkcja nerek”, “Digitalis”: “Digitalis”, “ACE Inhibitors/ARBs”: “Inhibitory ACE/ARBs”, “Aldosterone Antagonists”: “Antagoniści aldosteronu”, “Implantable Cardioverter-Defibrillator”: “Wszczepialny kardiowerter-defibrylator”, “sudden cardiac death”: “Nagła śmierć sercowa”, “Cardiac Resynchronization Therapy”: “Terapia resynchronizująca serca”, “Coronary Artery Bypass Grafting”: “Pomostowanie aortalno-wieńcowe”, “Heart Transplant”: “Przeszczep serca”, “impair”: “Upośledzać”, “Congestion”: “Zastój”, “eligible patients”: “Kwalifikujący się pacjenci”, “morbidity”: “Chorobowość”, “liver congestion”: “Przekrwienie wątroby”, “Acute Infective Endocarditis”: “Ostre infekcyjne zapalenie wsierdzia”, “Subacute Infective Endocarditis”: “Podostre infekcyjne zapalenie wsierdzia”, “susceptible”: “Podatny”, “Prosthetic”: “Proteza”, “Previous Endocarditis”: “Przebyte zapalenie wsierdzia”, “Poor Dental Hygiene”: “Słaba higiena jamy ustnej”, “bacteremia”: “Bakteriemia”, “bloodstream”: “Krwiobieg”, “endocardium”: “Wsierdzie”, “embolic events”: “Zdarzenia zatorowe”, “Fever and Chills”: “Gorączka i dreszcze”, “Petechiae”: “Wybroczyny”, “Osler Nodes”: “Guzki Oslera”, “Janeway Lesions”: “Zmiany Janewaya”, “Splinter Hemorrhages”: “Krwotoki podpaznokciowe”, “Roth Spots”: “Plamki Rotha”, “Retinal hemorrhages”: “Krwotoki siatkówkowe”, “pulmonary embolism”: “Zatorowość płucna”, “organ infarction”: “Zawał narządu”, “Blood Cultures”: “Posiewy krwi”, “samples”: “Próbki”, “Transesophageal echocardiography”: “Echokardiografia przezprzełykowa”, “transthoracic echocardiography”: “Echokardiografia przezklatkowa”, “Complete Blood Count”: “Morfologia krwi”, “C-Reactive Protein”: “Białko C-reaktywne (CRP)”, “Erythrocyte Sedimentation Rate”: “Odczyn Biernackiego (OB)”, “systemic inflammation”: “Stan zapalny ogólnoustrojowy”, “Urinalysis”: “Badanie moczu”, “hematuria”: “Krwiomocz”, “intravenous antibiotics”: “Antybiotyki dożylne”, “Empirical broad-spectrum antibiotics”: “Empiryczne antybiotyki o szerokim spektrum działania”, “embolism”: “Zator”, “abscess formation”: “Tworzenie ropnia”, “Prophylactic Antibiotics”: “Antybiotyki profilaktyczne”, “endocarditis”: “Zapalenie wsierdzia”, “Perivalvular Extension”: “Rozprzestrzenianie okołozastawkowe”, “Glomerulonephritis”: “Kłębuszkowe zapalenie nerek”, “Immune-mediated kidney inflammation”: “Zapalenie nerek zależne od układu odpornościowego”, “immune complex”: “Kompleks immunologiczny”, “glomeruli”: “Kłębuszki nerkowe”, “Prompt Treatment”: “Szybkie leczenie”, “mortality rate”: “Wskaźnik śmiertelności”, “antibiotic therapy”: “Terapia antybiotykowa”, “septic embolism”: “Zator septyczny”, “comorbidities”: “Choroby współistniejące”, “prosthetic valve involvement”: “Zajęcie protez zastawkowych” }; // Normalize keys in the dictionary const normalizedWordsToTooltip = {}; for (const [key, value] of Object.entries(wordsToTooltip)) { const cleanedKey = key.replace(/(.*?)/g, ”).trim(); // Remove anything in parentheses normalizedWordsToTooltip[cleanedKey.toLowerCase()] = value; } function processNode(node) { if (node.nodeType === Node.TEXT_NODE && node.nodeValue.trim()) { let content = node.nodeValue; // Regex to match only the main words (ignores parentheses) const regex = new RegExp( `\b(${Object.keys(normalizedWordsToTooltip).join(‘|’)})\b`, ‘gi’ ); if (regex.test(content)) { const wrapper = document.createElement(‘span’); wrapper.innerHTML = content.replace(regex, (match) => { const tooltip = normalizedWordsToTooltip[match.toLowerCase().trim()]; return `${match}`; }); node.replaceWith(wrapper); } } else if (node.nodeType === Node.ELEMENT_NODE) { Array.from(node.childNodes).forEach(processNode); } } document.querySelectorAll(‘body *:not(script):not(style)’).forEach((element) => { Array.from(element.childNodes).forEach(processNode); }); });

Valvular Heart Disease

Valvular heart disease affects one or more of the heart valves (aortic, mitral, tricuspid, or pulmonary). These conditions can result in stenosis, where the valve does not open fully, or regurgitation, where the valve does not close properly, causing blood to flow backward.

Types of Valvular Heart Disease

Type	Description
Aortic Stenosis	The aortic valve narrows, restricting blood flow from the left ventricle to the aorta. This condition often results in symptoms such as chest pain, shortness of breath, and syncope, especially during physical exertion.
Mitral Regurgitation	The mitral valve does not close tightly, allowing blood to flow backward into the left atrium. Patients may experience fatigue, dyspnea on exertion, or palpitations.
Mitral Stenosis	The mitral valve narrows, impeding blood flow from the left atrium to the left ventricle. Symptoms often include breathlessness, particularly during physical activity or when lying flat, and hemoptysis in severe cases.
Aortic Regurgitation	The aortic valve fails to close properly, causing blood to leak back into the left ventricle. Signs may include fatigue, dyspnea, and a characteristic “water hammer” pulse.

Etiology and Risk Factors

• Rheumatic Fever: A significant cause of valvular disease, particularly mitral stenosis, resulting from untreated streptococcal infections.
• Congenital Heart Defects: Valvular abnormalities present from birth, such as bicuspid aortic valve.
• Age-Related Degeneration: Calcification and fibrosis of valves, commonly seen in aortic stenosis.
• Infective Endocarditis: Infection of the heart valves, which can damage and deform valve structure.
• Other Factors: Connective tissue disorders (e.g., Marfan syndrome), previous myocardial infarction, and certain autoimmune diseases.

Pathophysiology

Valvular disease leads to either obstruction of blood flow (stenosis) or leakage (regurgitation), placing extra strain on the heart. Over time, this can cause hypertrophy of the ventricles, dilation of the atria, or congestive heart failure. The severity of symptoms depends on which valve is affected and the degree of dysfunction.

Clinical Manifestations

• Chest Pain (Angina): Common in aortic stenosis due to increased myocardial oxygen demand.
• Shortness of Breath: A result of heart failure or pulmonary congestion, particularly with mitral or aortic regurgitation.
• Fatigue and Weakness: Due to decreased cardiac output.
• Heart Murmur: An abnormal sound heard on auscultation, often the first clue to valvular disease.
• Palpitations: From atrial fibrillation secondary to valvular disease, especially mitral stenosis.
• Peripheral Edema: Swelling in the legs, ankles, and feet, associated with advanced heart failure.

Diagnostic Approach

• Echocardiogram: The gold standard for evaluating valve structure and function, measuring pressure gradients and regurgitation severity.
• Chest X-Ray: To assess heart size and signs of pulmonary congestion.
• Electrocardiogram (ECG): Identifies atrial enlargement, ventricular hypertrophy, or rhythm abnormalities.
• Cardiac Catheterization: Used to measure pressures within the heart chambers and evaluate for coronary artery disease if surgical intervention is considered.
• MRI and CT Scan: For more detailed imaging of the heart and valves.

Treatment

• Medications:
  • Diuretics: To relieve fluid overload in heart failure.
  • Beta-Blockers and Calcium Channel Blockers: To manage heart rate and blood pressure.
  • Anticoagulants: In patients with atrial fibrillation to prevent stroke.
• Surgical Interventions:
  • Valve Repair: Preferred for conditions like mitral regurgitation.
  • Valve Replacement: Using mechanical or bioprosthetic valves, required for severe aortic or mitral valve disease.
• Percutaneous Procedures:
  • Transcatheter Aortic Valve Replacement (TAVR): A minimally invasive option for aortic stenosis.
  • Balloon Valvuloplasty: For temporary relief of stenosis, particularly in younger patients or those not suitable for surgery.
• Lifestyle Modifications: Reducing sodium intake, managing blood pressure, and following an appropriate exercise plan.

Complications

• Heart Failure: Due to chronic overloading of the heart chambers.
• Arrhythmias: Such as atrial fibrillation, increasing the risk of stroke.
• Pulmonary Hypertension: Often a consequence of mitral valve disease.
• Infective Endocarditis: Especially in those with prosthetic valves or severe valve damage.
• Thromboembolism: Blood clots may form in the heart chambers and travel to other organs.

Prognosis for Valvular Heart Disease

Aortic Stenosis (AS)

• Mild to Moderate Cases: Patients can remain asymptomatic for many years. With regular monitoring and management of risk factors, life expectancy may be close to normal.
• Severe Symptomatic AS: Once symptoms develop (e.g., chest pain, syncope, or heart failure), the prognosis worsens significantly, with a median survival of 2-3 years without surgical intervention. Valve replacement greatly improves survival and quality of life.

Mitral Regurgitation (MR)

• Early Stages: Asymptomatic patients with mild or moderate MR often have a favorable prognosis with close follow-up.
• Severe MR: If untreated, it leads to left ventricular dysfunction and heart failure. Surgical repair or replacement, when indicated, significantly improves outcomes, with a 10-year survival rate of 75-85% for successful valve repair.

Mitral Stenosis (MS)

• Mild Cases: Patients may remain stable for years with minimal symptoms. However, the disease often progresses over time.
• Severe MS: Untreated cases can lead to pulmonary hypertension and right heart failure. Mitral valve interventions, such as percutaneous balloon valvuloplasty or valve replacement, can alleviate symptoms and improve survival.

Aortic Regurgitation (AR)

• Chronic Asymptomatic AR: Patients can have a normal life expectancy with regular monitoring.
• Symptomatic AR: Progression to heart failure significantly impacts survival. Surgical valve replacement improves long-term outcomes, with a 10-year survival rate exceeding 80% in patients without significant comorbidities.

Congestive Heart Failure (CHF)

Congestive heart failure is a chronic condition in which the heart is unable to pump sufficient blood to meet the body’s needs. It can affect the left ventricle, right ventricle, or both. Over time, the heart muscle becomes weakened or stiff, leading to fluid buildup in the lungs, abdomen, and extremities.

Types of Congestive Heart Failure

Type	Description
Left-Sided Heart Failure	The most common form, occurring when the left ventricle fails to pump blood effectively to the rest of the body. It leads to fluid accumulation in the lungs (pulmonary congestion), causing symptoms like shortness of breath, orthopnea (difficulty breathing when lying flat), and paroxysmal nocturnal dyspnea (sudden breathlessness at night).
Right-Sided Heart Failure	Often a consequence of left-sided failure, but it can occur independently due to conditions like pulmonary hypertension. It results in fluid retention in the body, leading to symptoms such as swelling in the legs, ankles, or abdomen and jugular venous distension (JVD).
Biventricular Heart Failure	Involves both sides of the heart and presents with a combination of symptoms from both left and right-sided failure.

Etiology and Risk Factors

• Coronary Artery Disease: The most common cause, leading to ischemic damage to the heart muscle.
• Hypertension: Chronic high blood pressure increases the heart’s workload, causing the heart muscle to thicken and weaken over time.
• Cardiomyopathy: Diseases of the heart muscle, which can be genetic, alcohol-related, or due to infections or toxins.
• Valvular Heart Disease: Faulty heart valves force the heart to work harder, contributing to heart failure.
• Diabetes: Increases the risk of developing heart failure due to associated complications like coronary artery disease.
• Other Factors: Obesity, smoking, and a sedentary lifestyle.

Pathophysiology

In CHF, the heart’s reduced ability to pump blood leads to compensatory mechanisms, including activation of the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system. These mechanisms increase blood volume and vascular resistance, temporarily supporting cardiac output but eventually causing worsening heart function, fluid retention, and further strain on the heart.

Clinical Manifestations

• Dyspnea: Shortness of breath, especially during exertion or when lying down (orthopnea).
• Fatigue: Persistent tiredness and reduced ability to exercise or perform daily activities.
• Peripheral Edema: Swelling in the legs, ankles, and feet due to fluid retention.
• Jugular Venous Distension (JVD): Visible swelling of the jugular veins in the neck, indicating elevated central venous pressure.
• Pulmonary Congestion: Coughing, wheezing, or frothy sputum, often with crackles heard on auscultation.
• Rapid or Irregular Heartbeat: Palpitations or arrhythmias resulting from decreased heart function.
• Sudden Weight Gain: Due to fluid retention, often an early sign of worsening heart failure.

Diagnostic Approach

• Echocardiogram: Evaluates heart function, ejection fraction, and valve abnormalities.
• Chest X-Ray: Identifies signs of pulmonary congestion or heart enlargement.
• B-type Natriuretic Peptide (BNP) Levels: Elevated BNP levels are indicative of heart failure.
• Electrocardiogram (ECG): Detects arrhythmias, previous heart attacks, or left ventricular hypertrophy.
• Cardiac MRI: Provides detailed images of heart structure and function.
• Blood Tests: Assess kidney function, electrolytes, thyroid function, and markers of heart damage.

Treatment

• Lifestyle Modifications:
  • Dietary Changes: Low-sodium diet to reduce fluid retention.
  • Exercise: Tailored physical activity program to improve heart health.
  • Smoking Cessation: To prevent further damage to the heart.
• Medications:
  • Diuretics: To reduce fluid buildup and ease symptoms.
  • ACE Inhibitors/ARBs: To lower blood pressure and reduce heart strain.
  • Beta-Blockers: To slow the heart rate and improve heart function.
  • Aldosterone Antagonists: To block the effects of aldosterone and reduce fluid retention.
  • Digitalis: To strengthen heart contractions in selected cases.
• Device Therapy:
  • Implantable Cardioverter-Defibrillator (ICD): To prevent sudden cardiac death in patients with significant risk of arrhythmias.
  • Cardiac Resynchronization Therapy (CRT): To improve coordination of heart muscle contractions.
• Surgical Interventions:
  • Valve Repair or Replacement: If valvular disease is a contributing factor.
  • Coronary Artery Bypass Grafting (CABG): To improve blood flow in cases of coronary artery disease.
  • Heart Transplant: For end-stage heart failure when other treatments have failed.

Complications

• Kidney Damage: Reduced blood flow can impair kidney function.
• Arrhythmias: Irregular heartbeats that may be life-threatening.
• Liver Damage: Congestion in the liver can lead to liver dysfunction.
• Stroke: Due to the increased risk of blood clots in the heart chambers.
• Pulmonary Hypertension: Increased pressure in the lung arteries due to left-sided heart failure.

Prognosis for Congestive Heart Failure (CHF)

Left-Sided Heart Failure

• Mild to Moderate Cases: With optimal medical therapy and lifestyle modifications, many patients can live for years with a good quality of life. The 5-year survival rate is approximately 50%.
• Advanced Heart Failure: Prognosis is poor, with a 1-year mortality rate of 20-30% in patients with end-stage heart failure. Heart transplantation may be considered for eligible patients.

Right-Sided Heart Failure

• Secondary to Left-Sided Failure: Prognosis depends on managing underlying left-sided heart disease. Isolated right heart failure, often due to pulmonary hypertension, has a variable outlook based on the underlying cause.
• Chronic Right Heart Failure: Associated with significant morbidity, especially if complications like liver congestion or severe edema develop.

Infective Endocarditis

Infective endocarditis is an infection of the endocardial surface of the heart, typically involving the heart valves. It is a serious condition that can lead to severe complications if not treated promptly. The infection is most commonly caused by bacteria but can also be due to fungi or other microorganisms.

Types of Infective Endocarditis

Type	Description
Acute Infective Endocarditis	Develops suddenly and is caused by highly virulent organisms, such as Staphylococcus aureus. It progresses rapidly, leading to significant valve destruction and severe systemic symptoms within days.
Subacute Infective Endocarditis	Has a more gradual onset, typically caused by less virulent organisms, such as Streptococcus viridans. It may develop over weeks to months and often occurs in individuals with pre-existing heart conditions or damaged valves.

Etiology and Risk Factors

• Bacterial Infections: The most common cause, with organisms like Staphylococcus aureus, Streptococcus viridans, and Enterococcus species.
• Intravenous Drug Use: Increases the risk of infection by introducing bacteria directly into the bloodstream.
• Prosthetic Heart Valves: Artificial valves are more susceptible to infection.
• Congenital Heart Defects: Structural heart abnormalities increase the risk.
• Previous Endocarditis: A history of infective endocarditis is a significant risk factor.
• Poor Dental Hygiene: Can lead to bacteremia and subsequent infection of heart valves.

Pathophysiology

Infective endocarditis occurs when microorganisms in the bloodstream adhere to the endocardium, particularly on heart valves. These microbes form vegetations composed of fibrin, platelets, and inflammatory cells. These vegetations can damage the heart valves, leading to regurgitation or obstruction and can break off, causing embolic events in distant organs.

Clinical Manifestations

• Fever and Chills: The most common initial symptoms, reflecting systemic infection.
• Heart Murmur: Often a new or changing murmur, indicating valve involvement.
• Fatigue and Weakness: Due to the ongoing infection and reduced cardiac function.
• Petechiae: Small red or purple spots on the skin, caused by broken capillaries.
• Osler Nodes: Painful, red nodules found on the pads of the fingers or toes.
• Janeway Lesions: Painless, red or purple spots on the palms or soles.
• Splinter Hemorrhages: Tiny blood clots that run vertically under the fingernails.
• Roth Spots: Retinal hemorrhages with pale centers, observed during an eye exam.
• Embolic Events: May present as stroke, pulmonary embolism, or organ infarction.

Diagnostic Approach

• Blood Cultures: Essential for identifying the causative organism, usually requiring multiple samples.
• Echocardiogram: Used to visualize vegetations on the heart valves and assess the extent of valve damage. Transesophageal echocardiography (TEE) is more sensitive than transthoracic echocardiography (TTE).
• Complete Blood Count (CBC): Often shows anemia and elevated white blood cell count.
• C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR): Elevated, reflecting systemic inflammation.
• Urinalysis: May reveal hematuria due to embolic events affecting the kidneys.

Treatment

• Antibiotic Therapy:
  • Long-term, high-dose intravenous antibiotics, tailored based on the identified organism and its antibiotic susceptibility.
  • Empirical broad-spectrum antibiotics are started before culture results in life-threatening cases.
• Surgical Interventions:
  • Valve repair or replacement may be necessary for patients with severe valve damage, persistent infection despite antibiotics, or large vegetations posing a risk of embolism.
• Management of Complications:
  • Addressing heart failure, abscess formation, and embolic events as needed.
• Prophylactic Antibiotics: Recommended for high-risk individuals before dental or surgical procedures to prevent endocarditis.

Complications

• Heart Failure: Due to valve destruction or severe regurgitation.
• Embolic Events: Vegetations can break off and travel to organs, causing strokes, kidney infarctions, or pulmonary embolisms.
• Abscess Formation: Localized pockets of infection within the heart tissue.
• Perivalvular Extension: Infection spreading to surrounding heart structures, leading to conduction abnormalities.
• Glomerulonephritis: Glomerulonephritis: Immune-mediated kidney inflammation, resulting from immune complex deposition in the glomeruli, leading to impaired filtration and potential kidney damage.

Prognosis for Infective Endocarditis

Acute Infective Endocarditis

• Prompt Treatment: With early diagnosis and appropriate antibiotic therapy, the in-hospital mortality rate is around 15-20%, but it increases if complications like heart failure or septic embolism occur.
• Surgical Intervention: For severe cases, valve replacement surgery can improve survival rates, but the overall 1-year mortality remains high, especially in patients with comorbidities or prosthetic valve involvement.

Subacute Infective Endocarditis

• Gradual Onset: Has a better prognosis if treated early, with mortality rates lower than in acute cases. Long-term outcomes are favorable with proper treatment and preventive measures.